Rigshospitalet Uni of Hospital of Copenhagen

Copenhagen DK-2100

2 studies enrolling now · 5 studies all time

What they study most

Adult-type Diffuse Gliomas, Advanced Solid Tumors, Anal Carcinoma, Basal Cell Carcinoma (Unresectable or Metastatic), Cervical Cancer, Clear Cell Ovarian or Endometrial Carcinoma, Cutaneous Squamous Cell Carcinoma, Cyclin-dependent Kinase 12 Mutated Tumors, DNA Polymerase Epsilon Mutated Tumors (P286R and V411L), Esophageal Squamous Cell Carcinoma, Glioblastoma, Hematologic Malignancies

Studies at this site

• A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies — Recruiting now
• A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors — Recruiting now
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations — Stopped early
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors — Stopped early
• A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies — Stopped early